Overview

Trially.ai, an AI-powered clinical trial recruitment platform built by veterans from Epic, Cerner, and Zapier, partnered with Disrupt to build a content presence as sophisticated as its technology. The company needed a medical copywriting partner who could translate deeply technical, heavily regulated subject matter spanning AI, EHR architecture, and compliance frameworks such as HIPAA and FDA 21 CFR Part 11 into clear, credible content that could pass formal review. Disrupt delivered a library of compliance-reviewed blogs, white papers, and newsletter content that positions Trially as a credible leader in AI-powered recruitment.

The Challenge

Clinical trial recruitment is one of the most technically complex and heavily regulated spaces in healthcare, and Trially's content had to reflect that reality. With a sophisticated audience of sponsors, CROs, research coordinators, and healthcare executives, generic health content would not suffice. The company needed:

• A medical copywriting partner fluent in AI, large language models, EHR architecture, and clinical research methodology

• Content that translated deeply technical subject matter into clear, credible, and compelling writing

• Strict adherence to regulatory and compliance standards, including HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001

• Formal compliance review was built into the process for every piece before publication

The Disrupt Solution

Our work with Trially spanned three content formats, each serving a distinct role in their broader content and thought leadership strategy.

Blogging

The foundation of the engagement was a series of SEO blog posts covering the full breadth of Trially's platform and the clinical trial recruitment landscape in which it operates. Topics ranged from AI versus manual patient prescreening and the implications of landmark clinical research published in the Journal of the American Medical Association, to EHR data architecture, physician engagement barriers, data security infrastructure, and the future of protocol feasibility assessment. Each post required original research, precise technical language, and careful adherence to Trially's regulatory disclaimers and compliance standards, all while remaining accessible and engaging for readers across multiple professional backgrounds.

Whitepaper(s) 

Alongside the blog program, we developed a series of strategic white papers examining AI's role in transforming clinical trial recruitment, designed as gated assets for key stakeholders, including sponsors, CROs, and research institutions. The white paper required the depth, authority, and rigor that the format demands, combining industry data, regulatory context, and forward-looking analysis into a single high-impact resource built to reinforce Trially's position as a credible leader in AI-powered recruitment solutions.

Email Newsletter

We also supported Trially's LinkedIn newsletter, producing content tailored to their professional audience and aligned with the thought-leadership positioning established across the broader content program.